Biotech Spinoffs and Boardroom Shakeups Drive Hong Kong’s Mid-Cap FringesGlobal Report·Aug 18 at 04:43 AM01167-0.66%026800.00%
JW Cayman Therapeutics schedules board meeting to review interim resultsPUBT·Aug 12 at 03:32 AM02126+3.98%
The Great Hong Kong Bifurcation: Biotech Boom Meets Real Estate GloomGlobal Report·Aug 11 at 04:42 AM03883+5.13%02126+3.98%
The Forgotten Corners of Hong Kong: How Legacy Industrials Are Navigating 2026Global Report·Aug 8 at 04:21 AM02126+3.98%
Hong Kong's Mid-Cap Tech and Healthcare Firms Pivot to AI Integrations and Capital OptimizationGlobal Report·Jul 22 at 04:18 AM02643+1.68%07666-5.07%
JW Cayman Therapeutics files directors list with Hong Kong exchangePUBT·Jun 26 at 07:30 AM02126+3.98%
JW Cayman Therapeutics names CEO Feng Tian chairman after Cheng Liu retires from boardPUBT·Jun 26 at 07:09 AM02126+3.98%
Morgan Stanley lists thematic investment stock list for the Asia-Pacific region (including Japanese stocks) (table)AASTOCKS·Jan 19 at 09:47 PM603259-3.00%02359-0.39%
Morning Trend | JW THERAP-B Oversold Seeking Bottom, Where is the Sector Rotation Window Under Pharmaceutical Divergence?Technical Forecast·Dec 3, 2025 at 07:00 PM02126+3.98%
